Vagus nerve stimulation helps reduce drug-seeking behavior.
Vagus nerve stimulation modulates synaptic plasticity in the rat prefrontal cortex during the extinction of drug-seeking
This study is looking at how a treatment called vagus nerve stimulation might help people with addiction by reducing their cravings for drugs when they see things that remind them of using, and it's being tested on rats to see how it works in the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project ID | NIH-11012290 on NIH RePORTER |
What this research studies
This research investigates how vagus nerve stimulation (VNS) can help break the strong associations formed between drug use and cues that trigger cravings. By using animal models, specifically rats, the study examines how VNS can enhance the learning process that inhibits drug-seeking behaviors. The researchers will analyze changes in brain activity and synaptic function to understand how VNS can support the extinction of these learned behaviors, potentially leading to new treatment strategies for addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with substance use disorders who experience strong cravings triggered by specific cues.
Not a fit: Patients who do not have a history of substance use disorders or those who are not experiencing cravings may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that help individuals overcome addiction by reducing cravings and preventing relapse.
How similar studies have performed: Previous studies have shown that vagus nerve stimulation can positively influence learning and memory processes, suggesting potential success for this approach in addiction treatment.
Where this research is happening
Richardson, United States
- University of Texas Dallas — Richardson, United States (Active)
Researchers
- Principal investigator: Kroener, Sven — University of Texas Dallas
- Study coordinator: Kroener, Sven
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.